• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

重组人内皮抑素对人肺腺癌A549细胞放射敏感性的增强作用及其机制

Enhancement of recombinant human endostatin on the radiosensitivity of human pulmonary adenocarcinoma A549 cells and its mechanism.

作者信息

Jiang Xiao-dong, Qiao Yun, Dai Peng, Chen Qin, Wu Jin, Song Da-an, Li Shi-qiu

机构信息

Department of Radiology, Lianyungang First People's Hospital, Jiangsu, Lianyungang 222002, China.

出版信息

J Biomed Biotechnol. 2012;2012:301931. doi: 10.1155/2012/301931. Epub 2012 Jun 18.

DOI:10.1155/2012/301931
PMID:22778546
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3385971/
Abstract

We observed the effects of endostar on the radiosensitivity of pulmonary adenocarcinoma A549 cells and found that endostar inhibited A549 cell growth under normoxia and hypoxia in time and dose-dependent manners; the D(0) and D(q) values in control and endostar groups were (1.36 and 1.30) versus (1.019 and 1.015) under normoxia and (1.693 and 1.39) versus (2.453 and 1.026) under hypoxia, respectively; SER was 1.04 under normoxia and 1.22 under hypoxia in endostar group; under normoxia, the apoptosis rates in control, radiotherapy, endostar and combination groups were 15.9 ± 0.57%, 42.7 ± 0.37%, 19.9 ± 0.48%, and 41.5 ± 0.38%, respectively, with no significant difference between combination and radiotherapy groups; there was significant difference in G(2)/M phase cells between combination and radiotherapy groups (P = 0.028); under hypoxia, the apoptosis rates in the four groups were 16.7 ± 0.67%, 30.1 ± 0.95%, 26.7 ± 0.62%, and 36.3 ± 0.71%, respectively, with significant difference between combination and radiotherapy groups; G(2)/M phase cells were higher in combination group than radiotherapy group (P = 0.000); G(2)/M phase cells were higher in hypoxic combination group than in normoxic combination group (P = 0.003). Based on these results, we conclude that under hypoxia, endostar can enhance the radiosensitivity of A549 cells through G(2)/M arrest.

摘要

我们观察了恩度对肺腺癌A549细胞放射敏感性的影响,发现恩度在常氧和缺氧条件下均能以时间和剂量依赖性方式抑制A549细胞生长;常氧条件下对照组和恩度组的D(0)和D(q)值分别为(1.36和1.30)与(1.019和1.015),缺氧条件下分别为(1.693和1.39)与(2.453和1.026);恩度组常氧时的增敏比为1.04,缺氧时为1.22;常氧条件下,对照组、放疗组、恩度组及联合组的凋亡率分别为15.9±0.57%、42.7±0.37%、19.9±0.48%和41.5±0.38%,联合组与放疗组之间无显著差异;联合组与放疗组在G(2)/M期细胞方面存在显著差异(P = 0.028);缺氧条件下,四组的凋亡率分别为16.7±0.67%、30.1±0.95%、26.7±0.62%和36.3±0.71%,联合组与放疗组之间存在显著差异;联合组的G(2)/M期细胞高于放疗组(P = 0.000);缺氧联合组的G(2)/M期细胞高于常氧联合组(P = 0.003)。基于这些结果,我们得出结论,在缺氧条件下,恩度可通过使G(2)/M期阻滞来增强A549细胞的放射敏感性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/3385971/b600aaa76745/JBB2012-301931.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/3385971/c385bc31c6b0/JBB2012-301931.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/3385971/cce29450b19d/JBB2012-301931.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/3385971/3b0c6f376e48/JBB2012-301931.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/3385971/71fa5fdc0a48/JBB2012-301931.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/3385971/b600aaa76745/JBB2012-301931.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/3385971/c385bc31c6b0/JBB2012-301931.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/3385971/cce29450b19d/JBB2012-301931.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/3385971/3b0c6f376e48/JBB2012-301931.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/3385971/71fa5fdc0a48/JBB2012-301931.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/50fe/3385971/b600aaa76745/JBB2012-301931.005.jpg

相似文献

1
Enhancement of recombinant human endostatin on the radiosensitivity of human pulmonary adenocarcinoma A549 cells and its mechanism.重组人内皮抑素对人肺腺癌A549细胞放射敏感性的增强作用及其机制
J Biomed Biotechnol. 2012;2012:301931. doi: 10.1155/2012/301931. Epub 2012 Jun 18.
2
CpG-ODN 7909 increases radiation sensitivity of radiation-resistant human lung adenocarcinoma cell line by overexpression of Toll-like receptor 9.CpG-ODN 7909 通过过表达 Toll 样受体 9 增加辐射抗性人肺腺癌细胞系的辐射敏感性。
Cancer Biother Radiopharm. 2013 Sep;28(7):559-64. doi: 10.1089/cbr.2012.1450. Epub 2013 May 24.
3
Endostar down-regulates HIF-1 and VEGF expression and enhances the radioresponse to human lung adenocarcinoma cancer cells.恩度下调 HIF-1 和 VEGF 的表达,并增强人肺腺癌细胞的放射反应。
Mol Biol Rep. 2012 Jan;39(1):89-95. doi: 10.1007/s11033-011-0713-6. Epub 2011 May 13.
4
The effect of elemene on lung adenocarcinoma A549 cell radiosensitivity and elucidation of its mechanism.榄香烯对肺腺癌A549细胞放射敏感性的影响及其机制探讨
Clinics (Sao Paulo). 2015 Aug;70(8):556-62. doi: 10.6061/clinics/2015(08)05.
5
[Radiosensitizing effect of erlotinib on human lung adenocarcinoma cell line A549].[厄洛替尼对人肺腺癌细胞系A549的放射增敏作用]
Zhonghua Zhong Liu Za Zhi. 2013 Nov;35(11):819-23.
6
The inhibitory effects of rh-endostatin (YH-16) in combination with radiotherapy on lung adenocarcinoma A549 in mice and the underlying mechanisms.重组人血管内皮抑素(YH-16)联合放疗对小鼠肺腺癌A549的抑制作用及其潜在机制。
J Huazhong Univ Sci Technolog Med Sci. 2010 Feb;30(1):108-12. doi: 10.1007/s11596-010-0120-6. Epub 2010 Feb 14.
7
Endostatin exerts radiosensitizing effect in non-small cell lung cancer cells by inhibiting VEGFR2 expression.内皮抑素通过抑制 VEGFR2 表达发挥非小细胞肺癌细胞的放射增敏作用。
Clin Transl Oncol. 2016 Jan;18(1):18-26. doi: 10.1007/s12094-015-1319-6. Epub 2015 Nov 5.
8
Endostar, a recombined humanized endostatin, enhances the radioresponse for human nasopharyngeal carcinoma and human lung adenocarcinoma xenografts in mice.恩度,一种重组人源化内皮抑素,可增强人鼻咽癌和人肺腺癌异种移植瘤在小鼠体内的放射反应。
Cancer Sci. 2009 Aug;100(8):1510-9. doi: 10.1111/j.1349-7006.2009.01193.x. Epub 2009 May 21.
9
Arsenic trioxide inhibits the growth of human lung cancer cell lines via cell cycle arrest and induction of apoptosis at both normoxia and hypoxia.三氧化二砷通过在常氧和低氧条件下使细胞周期停滞并诱导凋亡来抑制人肺癌细胞系的生长。
Toxicol Ind Health. 2009 Sep;25(8):505-15. doi: 10.1177/0748233709345936.
10
Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation.通过联合靶向 DNA 依赖性蛋白激酶和碳离子放疗克服非小细胞肺癌缺氧诱导的肿瘤放射抵抗。
Radiat Oncol. 2017 Dec 29;12(1):208. doi: 10.1186/s13014-017-0939-0.

引用本文的文献

1
Recombinant Endostatin as a Potential Radiosensitizer in the Treatment of Non-Small Cell Lung Cancer.重组内皮抑素作为非小细胞肺癌治疗中一种潜在的放射增敏剂。
Pharmaceuticals (Basel). 2023 Jan 31;16(2):219. doi: 10.3390/ph16020219.
2
Recombinant human endostatin combined with radiotherapy promotes cardiomyocyte apoptosis in rats via TGFβ1/Smads/CTGF signaling pathway.重组人血管内皮抑制素联合放疗通过 TGFβ1/Smads/CTGF 信号通路促进大鼠心肌细胞凋亡。
BMC Cardiovasc Disord. 2022 Mar 12;22(1):97. doi: 10.1186/s12872-022-02499-8.
3
Anti-tumor effect of local injectable hydrogel-loaded endostatin alone and in combination with radiotherapy for lung cancer.

本文引用的文献

1
Cancer: Limitations of therapies exposed.癌症:已暴露的治疗局限性。
Nature. 2012 Apr 4;484(7392):44-6. doi: 10.1038/484044a.
2
Recombinant human endostatin improves anti-tumor efficacy of paclitaxel by normalizing tumor vasculature in Lewis lung carcinoma.重组人血管内皮抑制素通过使 Lewis 肺癌血管正常化增强紫杉醇的抗肿瘤疗效。
J Cancer Res Clin Oncol. 2010 Aug;136(8):1201-11. doi: 10.1007/s00432-010-0770-6. Epub 2010 Feb 4.
3
Pulmonary tumours in the Netherlands: focus on temporal trends in histology and stage and on rare tumours.
局部注射载内皮抑素水凝胶单独及联合放疗治疗肺癌的抗肿瘤作用。
Drug Deliv. 2021 Dec;28(1):183-194. doi: 10.1080/10717544.2020.1869864.
4
Efficacy and safety of recombinant human endostatin combined with radiotherapy or chemoradiotherapy in patients with locally advanced non-small cell lung cancer: a pooled analysis.重组人内皮抑素联合放疗或放化疗治疗局部晚期非小细胞肺癌患者的疗效与安全性:一项汇总分析
Radiat Oncol. 2020 Aug 24;15(1):205. doi: 10.1186/s13014-020-01646-9.
5
Different administration routes of recombinant human endostatin combined with concurrent chemoradiotherapy might lead to different efficacy and safety profile in unresectable stage III non-small cell lung cancer: Updated follow-up results from two phase II trials.不同给药途径的重组人血管内皮抑制素联合同期放化疗治疗局部晚期非小细胞肺癌的疗效和安全性:两项Ⅱ期临床试验的随访结果更新。
Thorac Cancer. 2020 Apr;11(4):898-906. doi: 10.1111/1759-7714.13333. Epub 2020 Feb 18.
6
Effects of combined inhibition of STAT3 and VEGFR2 pathways on the radiosensitivity of non-small-cell lung cancer cells.STAT3和VEGFR2通路联合抑制对非小细胞肺癌细胞放射敏感性的影响。
Onco Targets Ther. 2019 Jan 29;12:933-944. doi: 10.2147/OTT.S186559. eCollection 2019.
Thorax. 2008 Dec;63(12):1096-102. doi: 10.1136/thx.2007.095067. Epub 2008 Aug 4.
4
[Combined effects of endostatin gene transfer and ionizing radiation on lung adenocarcinoma model of A549-cells].[内皮抑素基因转染与电离辐射对A549细胞肺癌模型的联合作用]
Zhonghua Jie He He Hu Xi Za Zhi. 2004 Oct;27(10):683-6.
5
Radiation-enhanced endostatin gene expression and effects of combination treatment.辐射增强内皮抑素基因表达及联合治疗的效果
Technol Cancer Res Treat. 2005 Apr;4(2):193-202. doi: 10.1177/153303460500400208.
6
Global cancer statistics, 2002.2002年全球癌症统计数据。
CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108. doi: 10.3322/canjclin.55.2.74.
7
Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy.肿瘤血管正常化:抗血管生成治疗中的一个新兴概念。
Science. 2005 Jan 7;307(5706):58-62. doi: 10.1126/science.1104819.
8
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: role of oxygenation, angiopoietin-1, and matrix metalloproteinases.通过阻断VEGFR2实现血管正常化的动力学决定脑肿瘤对放疗的反应:氧合作用、血管生成素-1和基质金属蛋白酶的作用
Cancer Cell. 2004 Dec;6(6):553-63. doi: 10.1016/j.ccr.2004.10.011.
9
Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells.内皮抑素除了在结肠癌细胞中具有抗血管生成活性外,还表现出直接的抗肿瘤作用。
Hum Gene Ther. 2003 Jul 1;14(10):997-1008. doi: 10.1089/104303403766682250.
10
Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells.内皮抑素抑制头颈部鳞状细胞癌细胞的迁移和侵袭。
Anticancer Res. 2003 Mar-Apr;23(2B):1289-95.